Get the full picture
Sign in to uncover key details.
PR
Director, Clinical Operations
Get the full picture
Sign in to uncover key details.
Accent Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1050 Waltham St Ste 201, Lexington, Mass...Phone Number
(339) 970-7400Website
www.accenttx.comRevenue
$5.8 MillionIndustry
About Accent Therapeutics
Accent Therapeutics is focused on translating advanced scientific research into innovative therapies for cancer patients. The company applies its expertise in RNA-modifying protein biology to develop small molecule therapeutics targeting critical intracellular dependencies across various cancer types. With a strong pipeline of first-in-class and best-in-class programs, Accent aims to meet the significant unmet medical needs of large patient populations. Their collaborative team is dedicated to driving the development of life-changing therapeutics for those living with cancer.Explore more
Accent Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Accent Therapeutics
Compare insights from companies similar to Accent Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Accent Therapeutics Tech Stack
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Accent Therapeutics
Sign Up For FreeTo access detailed company insights
Accent Therapeutics is focused on translating advanced scientific research into innovative therapies for cancer patients. The company applies its expertise in RNA-modifying protein biology to develop small molecule therapeutics targeting critical intracellular dependencies across various cancer types. With a strong pipeline of first-in-class and be... Read More
